Back to Search
Start Over
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
- Source :
- International Journal of Gynecological Cancer; Apr2023, Vol. 33 Issue 4, p562-570, 9p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 1048891X
- Volume :
- 33
- Issue :
- 4
- Database :
- Supplemental Index
- Journal :
- International Journal of Gynecological Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 163545006
- Full Text :
- https://doi.org/10.1136/ijgc-2022-003927